<ѻý>NASH Drug Candidate Comes With 'Serious Risks,' Says FDA Staffѻý> Agency reviewers signal little support for first potential nonalcoholic steatohepatitis drug May 17, 2023
<ѻý>The Broader Significance of a New Drug for a Rare Form of ALSѻý> The tofersen trial offers hope and lessons for the fight against ALS May 15, 2023
<ѻý>Duchenne Muscular Dystrophy Treatment Narrowly Captures Support of FDA Advisorsѻý> Whether vote means FDA will approve Sarepta's gene therapy remains to be seen May 13, 2023
<ѻý>FDA OKs Hormone-Free Pill for Hot Flashesѻý> First-in-class drug works by blocking the NK3 receptor, which plays role in regulating body temp May 12, 2023
<ѻý>Bill to Study Xylazine Passes House, Advances in Senateѻý> Measure does not address scheduling the drug, which is frequently added to fentanyl May 12, 2023
<ѻý>FDA Updates Warnings on All Stimulants for ADHD, Other Conditionsѻý> New language emphasizes potential for misuse, abuse, addiction, and overdose May 12, 2023
<ѻý>FDA Panel Backs Needle-Free Epinephrine for Anaphylaxisѻý> Choice of alternative route with nasal spray outweighs possible risks, panelists say May 12, 2023
<ѻý>FDA Relaxes Blood Donation Rules for Gay and Bisexual Menѻý> New guidance ditches MSM-specific screening questions in effort to expand eligibility May 11, 2023
<ѻý>FDA OKs First Drug for Agitation in Alzheimer's Dementiaѻý> Boxed warning on increased mortality risk in elderly patients remains for brexpiprazole May 11, 2023
<ѻý>Sarepta's Duchenne Gene Therapy Does Not Have 'Unambiguous Evidence,' FDA Staff Saysѻý> Agency reviewers question micro-dystrophin as a surrogate endpoint May 10, 2023
<ѻý>FDA Staff Grapples With Absent Clinical Efficacy Data for Nasal Epinephrineѻý> No precedent for approval of noninjectable epinephrine for anaphylaxis, noted agency reviewers May 10, 2023
<ѻý>Proposed Breast Cancer Screening Guidelines Are Good, but Not Enoughѻý> Specifics for older women, Black women, and those with dense breasts are needed May 09, 2023
<ѻý>FDA Reviewers Raise Multiple Issues on OTC Birth Control Pillѻý> Is labeling enough for users to take the drug correctly and self-deselect? May 05, 2023
<ѻý>Forging the Path to a West Nile Vaccineѻý> Alternative approaches to licensure are key, says CDC's Carolyn Gould May 04, 2023 video
<ѻý>Why Is One Dose Suddenly Enough for the mRNA COVID Vaccines?ѻý> FDA and CDC have made yet another questionable decision May 02, 2023
<ѻý>FDA Panel Rejects Broad Olaparib Indication in Metastatic CRPCѻý> ODAC votes that olaparib-abiraterone combination should be restricted to BRCA-positive subset Apr 28, 2023
<ѻý>Patients Living With Long COVID Offer Insight to FDAѻý> Agency sought feedback on outcomes that matter most to patients Apr 28, 2023
<ѻý>FDA Extends Trikafta Approval to Even Younger Cystic Fibrosis Patientsѻý> Patients ages 2 to 5 years now eligible for the triple therapy Apr 27, 2023
<ѻý>FDA OKs First Poop-Based Oral Therapyѻý> Vowst approved for preventing recurrent C. difficile infections after antibiotics Apr 27, 2023
<ѻý>Be Wary of Amniotic Fluid Eye Drops, FDA Saysѻý> Agency sends another salvo in battle with birth-tissue industry Apr 24, 2023
<ѻý>FDA Finally OKs Latest MiniMed System for Type 1 Diabetesѻý> 780G system first to feature meal detection technology Apr 24, 2023
<ѻý>Thumbs Down From FDA Panel on Plastic Meniscus Replacementѻý> Members unimpressed with efficacy, safety data Apr 21, 2023
<ѻý>Who Are the Doctors Suing FDA Over the Abortion Pill?ѻý> Four physicians are named as plaintiffs alongside the Alliance for Hippocratic Medicine Apr 20, 2023
<ѻý>FDA Panelists Slam Agency's Proposed Opioid Trial Designѻý> Advisors said outcomes from an enriched enrollment study would not be broadly generalizable Apr 20, 2023
<ѻý>Antibody-Drug Conjugate Gets FDA Thumbs Up for Untreated DLBCLѻý> Adding polatuzumab vedotin to a modified version of R-CHOP significantly improved PFS Apr 20, 2023
<ѻý>FDA Mulling Trial Design Issues for Long-Term Opioids in Chronic Painѻý> Agency advisors will consider pros, cons of an enriched enrollment randomized withdrawal design Apr 17, 2023
<ѻý>FDA Advisors Endorse Rexulti for Agitation in Alzheimer's Dementiaѻý> Increased mortality risk seen but benefits may outweigh this, panelists say Apr 14, 2023
<ѻý>FDA Panel to Weigh Limited Data on Combo for Healthcare-Acquired Pneumoniaѻý> Sulbactam-durlobactam under consideration for cases caused by Acinetobacter spp. Apr 14, 2023
<ѻý>All Opioid Pain Meds to Get New Safety Warnings, FDA Saysѻý> Updated labeling to include warning about opioid-induced hyperalgesia Apr 13, 2023
<ѻý>Rexulti Works for Agitation in Alzheimer's, Despite Risks, Says FDA Staffѻý> Increased mortality risk consistent with other antipsychotics in elderly dementia patients Apr 13, 2023
<ѻý>Reworked Philips CPAP, BiPAP Machines May Not Deliver Correct Therapyѻý> And some of the remediated breathing devices may not provide any treatment at all, FDA warns Apr 10, 2023
<ѻý>FDA Approval Authority in Jeopardy? TB Hits the Casino; Sen. Blumenthal's Surgeryѻý> Health news and commentary from around the Web gathered by ѻý staff Apr 10, 2023
<ѻý>FDA Yanks Only Preterm Birth Drug, Effective Immediatelyѻý> Months after advisors recommended Makena's approval be withdrawn, FDA announces final decision Apr 06, 2023
<ѻý>Mail-Back Envelopes Will Be Dispensed With Outpatient Opioid Scriptsѻý> Strategy will provide another option to dispose of unneeded medications, FDA says Apr 03, 2023
<ѻý>Do Away With 'Lockout' Period in iPLEDGE, FDA Advisors Urgeѻý> It's an "unduly high burden" on patients, says one advisory committee member Mar 29, 2023
<ѻý>Isotretinoin REMS Still Needed, but Its Burden Could Be Reduced, FDA Staff Saysѻý> Report suggests ways to lighten documentation rules for prescribing the severe acne treatment Mar 27, 2023
<ѻý>FDA Greenlights First Drug for Rare Immunodeficiency Diseaseѻý> Activated PI3K-delta syndrome may have a new standard of care Mar 27, 2023
<ѻý>FDA Faults Next-Gen Olympus Duodenoscopesѻý> After demanding single-use devices, agency finds they have their own problems Mar 27, 2023
<ѻý>FDA: Watch for Joint Replacement Device Failure After Exactech Recallѻý> Revision surgery only recommended for patients with pain Mar 23, 2023
<ѻý>FDA Panel Supports Tofersen for Rare Genetic ALSѻý> In a first, agency advisors back neurofilament light as a surrogate endpoint Mar 23, 2023